Le Lézard
Classified in: Health
Subject: PER

Lorrie A. Carr Appointed as CEO for Excelera


MINNEAPOLIS, July 16, 2018 /PRNewswire/ -- "After a thorough and deliberate selection process, the Board of Directors is delighted that Lorrie will lead Excelera as we navigate the dynamic and evolving specialty pharmacy industry," said Robert Beacher, Chairman of the Board and interim CEO for Excelera. "Lorrie has a very diverse background within the biopharma and specialty pharmacy sectors, which will allow her to build upon our industry-leading position supporting our Members in caring for complex patients. I have no doubt that she is the right person to lead Excelera into new and innovative growth opportunities."

Prior to joining Excelera, Ms. Carr was the Chief Commercial Officer for ZappRx ? a healthcare technology company whose mission is to alleviate barriers that prevent patient access to life-saving specialty medications. Before ZappRx, Ms. Carr held an executive role within Walgreens Specialty Pharmacy as the Divisional VP of Enterprise Specialty Sales and Product Management. Ms. Carr started her career in the biopharmaceutical industry where she held leadership roles in global market access, reimbursement, managed care, marketing and network development.

"It is my great privilege to have been chosen to lead an innovative specialty healthcare company like Excelera," said Carr. "I am honored to have the opportunity to work with a team of very talented employees and an industry-leading Board of Directors. As CEO, my primary objectives will be to continue the great work that has been started, develop innovative strategies designed to grow and leverage our membership, and build meaningful partnerships with biopharmaceutical clients."

Ms. Carr received her bachelor's degree from Columbia College and holds her MBA from UMASS Isenberg School of Management.

About Excelera 
ExceleraRx Corp. supports the Excelera® Specialty Pharmacy Network, a national network of specialty pharmacies based at health systems and academic medical centers, enabling member organizations to gain access to limited distribution drugs and restricted payer agreements. The Excelera network provides national-scale efficiency and collaboration to improve quality and value of outpatient specialty drug therapy. For a current list of Excelera specialty pharmacy network members, or for more information about becoming a member of the Excelera network, visit excelerarx.com or follow us on LinkedIn.

 

ExceleraRx Corp. Logo

SOURCE ExceleraRx Corp.


These press releases may also interest you

at 23:19
Summit Clinical Research LLC ("Summit") is deeply saddened by the death of Co-Founder and Chairman Dr. Stephen Harrison. Summit mourns Dr. Harrison and extends its heartfelt condolences to his family and loved ones.   During an illustrious 30-year...

at 22:15
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

at 21:59
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

at 21:27
Labcorp , a global leader of innovative and comprehensive laboratory services, announced today that it has been selected as the winning bidder for select assets of Invitae, a leading medical genetics company.  Before the transaction can proceed,...

at 21:19
Invitae , a leading medical genetics company, announced that Labcorp , a global leader of innovative and comprehensive laboratory services, has been selected...

at 21:05
Valcare Medical, Inc., a leading innovator in transcatheter-based mitral...



News published on and distributed by: